3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
22
Phase 2
9
Phase 1/2
5
Phase 3
4
Phase EARLY_PHASE1
2
Phase NA
1
Phase 4
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
3856
Gastrointestinal
277
Genitourinary
209
Gynecologic
178
Thoracic
161
Head & Neck
72
Other
66
Lymphoid
62
Dermatologic
59
CNS
54
Sarcoma
39
Other hematologic neoplasm
35
Plasma cell
29
Myeloid
15
Classical hematology
9
Other solid neoplasm
3
Other neoplasm
2
Endocrine
1
Conditions
Multiple Endocrine Neoplasia Type 1
96
Pituitary Neoplasms
56
Neuroendocrine Tumors
50
Thyroid Cancer, Papillary
42
Thyroid Neoplasms
16
Obesity
15
Pheochromocytoma
14
Overweight
11
Adrenal Gland Neoplasms
10
Weight Loss
9
Paraganglioma
9
Carcinoma, Neuroendocrine
9
Pancreatic Neoplasms
8
Prostatic Neoplasms
7
Motor Activity
7
Insulinoma
7
Gastrointestinal Neoplasms
7
Brain Neoplasms
7
Adrenocortical Adenoma
7
Acquired Immunodeficiency Syndrome
7
Neoplasm Metastasis
6
Hyperaldosteronism
6
Carcinoma, Medullary
6
Stomach Neoplasms
5
Osteoporosis
5
Neoplasms
5
Meningioma
5
Liver Neoplasms
5
Insulin Resistance
5
HIV Infections
5
Interventions
Standard of Care
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase NA
×
Breast Neoplasms
×
Endocrine
×
Clear all
NCT02957981
2023-09-13
GEM
Georgetown University
Phase NA
Completed
63 enrolled